COMPOSITIONS AND METHODS FOR PHARMACOGENOMIC SCREENING OF CYP2C9 AND VKORC1

摘要

Compositions and methods for determining an optimal dose of a medication for a subject are described that include determining the subject's genotype for the CYP2C9 and VKORC1 genes and determining the dose of the medication based on the genotype. Articles of manufacture also are provided that include polynucleotides for genotyping.